Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity

Human Molecular Genetics

Volumn 21, Issue 6, 2012, Pages 1203-1216

  Giralt, A ^a,b,c   Puigdellivol M ^a,b,c   Carreton O ^a,b,c   Paoletti, P ^a,b,c   Valero, J ^c,d   Parra damas, A ^c,d   Saura, C A ^c,d   Alberch, J ^a,b,c   Gines S ^a,b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE H3; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN C FOS; TRICHOSTATIN A;

AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HETEROZYGOTE; HIPPOCAMPUS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; LONG TERM MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOGNITION; WILD TYPE;

ACETYLATION; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; COGNITION DISORDERS; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; FEMALE; GENES, FOS; HIPPOCAMPUS; HISTONE ACETYLTRANSFERASES; HUMANS; HUNTINGTON DISEASE; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MALE; MAZE LEARNING; MEMORY, LONG-TERM; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 84857674697     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr552     Document Type: Article

References (86)

1. Lawrence, A.D., Hodges, J.R., Rosser, A.E., Kershaw, A., Ffrench-Constant, C., Rubinsztein, D.C., Robbins, T.W. and Sahakian, B.J. (1998) Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 121, 1329-1341.
2. Montoya, A., Pelletier, M., Menear, M., Duplessis, E., Richer, F. and Lepage, M. (2006) Episodic memory impairment in Huntington's disease: a meta-analysis. Neuropsychologia, 44, 1984-1994.
3. Stout, J.C., Paulsen, J.S., Queller, S., Solomon, A.C., Whitlock, K.B., Campbell, J.C., Carlozzi, N., Duff, K., Beglinger, L.J., Langbehn, D.R et al. (2010) Neurocognitive signs in prodromal Huntington disease. Neuropsychology, 25, 1-14.
4. Vonsattel, J.P. and DiFiglia, M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol., 57, 369-384.
5. Brooks, S., Higgs, G., Jones, L. and Dunnett, S.B. (2010) Longitudinal analysis of the behavioural phenotype in Hdh(Q92) Huntington's disease knock-in mice. Brain Res. Bull., doi:10.106/j.brainresbull.2010.05.003.
6. Giralt, A., Rodrigo, T., Martin, E.D., Gonzalez, J.R., Mila, M., Cena, V., Dierssen, M., Canals, J.M. and Alberch, J. (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience, 158, 1234-1250.
7. Lione, L.A., Carter, R.J., Hunt, M.J., Bates, G.P., Morton, A.J. and Dunnett, S.B. (1999) Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci., 19, 10428-10437.
8. Lynch, G., Kramar, E.A., Rex, C.S., Jia, Y., Chappas, D., Gall, C.M. and Simmons, D.A. (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J. Neurosci., 27, 4424-4434.
9. Simmons, D.A., Rex, C.S., Palmer, L., Pandyarajan, V., Fedulov, V., Gall, C.M. and Lynch, G. (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc. Natl Acad. Sci. USA, 106, 4906-4911.
10. Barco, A., Pittenger, C. and Kandel, E.R. (2003) CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin. Ther. Targets, 7, 101-114.
11. Kandel, E.R. (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science, 294, 1030-1038.
12. Silva, A.J., Kogan, J.H., Frankland, P.W. and Kida, S. (1998) CREB and memory. Annu. Rev. Neurosci., 21, 127-148.
13. Rosenfeld, M.G. and Glass, C.K. (2001) Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem., 276, 36865-36868.
14. Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G. and Silva, A.J. (1994) Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell, 79, 59-68.
15. Chrivia, J.C., Kwok, R.P., Lamb, N., Hagiwara, M., Montminy, M.R. and Goodman, R.H. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature, 365, 855-859.
16. Ravnskjaer, K., Kester, H., Liu, Y., Zhang, X., Lee, D., Yates, J.R III and Montminy, M. (2007) Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J., 26, 2880-2889.
17. Kalkhoven, E. (2004) CBP and p300: HATs for different occasions. Biochem. Pharmacol., 68, 1145-1155.
18. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
19. Vo, N. and Goodman, R.H. (2001) CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem., 276, 13505-13508.
20. Chan, H.M. and La Thangue, N.B. (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci., 114, 2363-2373.
21. Alarcon, J.M., Malleret, G., Touzani, K., Vronskaya, S., Ishii, S., Kandel, E.R. and Barco, A. (2004) Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron, 42, 947-959.
22. Chen, G., Zou, X., Watanabe, H., van Deursen, J.M. and Shen, J. (2010) CREB binding protein is required for both short-term and long-term memory formation. J. Neurosci., 30, 13066-13077.
23. Valor, L.M., Pulopulos, M.M., Jimenez-Minchan, M., Olivares, R., Lutz, B. and Barco, A. (2011) Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability. J. Neurosci., 31, 1652-1663.
24. Jiang, H., Poirier, M.A., Liang, Y., Pei, Z., Weiskittel, C.E., Smith, W.W., DeFranco, D.B. and Ross, C.A. (2006) Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. Neurobiol. Dis., 23, 543-551.
25. McCampbell, A., Taye, A.A., Whitty, L., Penney, E., Steffan, J.S. and Fischbeck, K.H. (2001) Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc. Natl Acad. Sci. USA, 98, 15179-15184.
26. Nucifora, F.C Jr, Sasaki, M., Peters, M.F., Huang, H., Cooper, J.K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V.L., Dawson, T.M. and Ross, C.A. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science, 291, 2423-2428.
27. Taylor, J.P., Taye, A.A., Campbell, C., Kazemi-Esfarjani, P., Fischbeck, K.H. and Min, K.T. (2003) Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein. Genes Dev., 17, 1463-1468.
28. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature, 413, 739-743.
29. Cong, S.Y., Pepers, B.A., Evert, B.O., Rubinsztein, D.C., Roos, R.A., van Ommen, G.J. and Dorsman, J.C. (2005) Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol. Cell Neurosci., 30, 12-23.
30. McCampbell, A., Taylor, J.P., Taye, A.A., Robitschek, J., Li, M., Walcott, J., Merry, D., Chai, Y., Paulson, H., Sobue, G. and Fischbeck, K.H. (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet., 9, 2197-2202.
31. Ferrante, R.J., Kubilus, J.K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N.W., Ratan, R.R., Luthi-Carter, R. and Hersch, S.M. (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci., 23, 9418-9427.
32. Gardian, G., Browne, S.E., Choi, D.K., Klivenyi, P., Gregorio, J., Kubilus, J.K., Ryu, H., Langley, B., Ratan, R.R., Ferrante, R.J. and Beal, M.F. (2005) Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J. Biol. Chem., 280, 556-563.
33. Lawrence, A.D., Sahakian, B.J., Hodges, J.R., Rosser, A.E., Lange, K.W. and Robbins, T.W. (1996) Executive and mnemonic functions in early Huntington's disease. Brain, 119, 1633-1645.
34. Montoya, A., Price, B.H., Menear, M. and Lepage, M. (2006) Brain imaging and cognitive dysfunctions in Huntington's disease. J. Psychiatry Neurosci., 31, 21-29.
35. Lloret, A., Dragileva, E., Teed, A., Espinola, J., Fossale, E., Gillis, T., Lopez, E., Myers, R.H., Macdonald, M.E. and Wheeler, V.C. (2006) Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice. Hum. Mol. Genet., 15, 2015-2024.
36. Jiang, H., Nucifora, F.C Jr, Ross, C.A. and DeFranco, D.B. (2003) Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum. Mol. Genet., 12, 1-12.
37. Herndon, E.S., Hladik, C.L., Shang, P., Burns, D.K., Raisanen, J. and White, C.L III (2009) Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains. J. Neuropathol. Exp. Neurol., 68, 250-261.
38. Wang, J., Wang, C.E., Orr, A., Tydlacka, S., Li, S.H. and Li, X.J. (2008) Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J. Cell Biol., 180, 1177-1189.
39. Barrett, R.M. and Wood, M.A. (2008) Beyond transcription factors: the role of chromatin modifying enzymes in regulating transcription required for memory. Learn. Mem., 15, 460-467.
40. Korzus, E., Rosenfeld, M.G. and Mayford, M. (2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron, 42, 961-972.
41. Francis, Y.I., Fa, M., Ashraf, H., Zhang, H., Staniszewski, A., Latchman, D.S. and Arancio, O. (2009) Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. J. Alzheimers Dis., 18, 131-139.
42. Vecsey, C.G., Hawk, J.D., Lattal, K.M., Stein, J.M., Fabian, S.A., Attner, M.A., Cabrera, S.M., McDonough, C.B., Brindle, P.K., Abel, T. and Wood, M.A. (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J. Neurosci., 27, 6128-6140.
43. Duff, K., Paulsen, J.S., Beglinger, L.J., Langbehn, D.R., Wang, C., Stout, J.C., Ross, C.A., Aylward, E., Carlozzi, N.E. and Queller, S. (2010) 'Frontal' behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J. Neuropsychiatry Clin. Neurosci., 22, 196-207.
44. Ho, A.K., Sahakian, B.J., Brown, R.G., Barker, R.A., Hodges, J.R., Ane, M.N., Snowden, J., Thompson, J., Esmonde, T., Gentry, R., Moore, J.W. and Bodner, T. (2003) Profile of cognitive progression in early Huntington's disease. Neurology, 61, 1702-1706.
45. Kirkwood, S.C., Siemers, E., Hodes, M.E., Conneally, P.M., Christian, J.C. and Foroud, T. (2000) Subtle changes among presymptomatic carriers of the Huntington's disease gene. J. Neurol. Neurosurg. Psychiatry, 69, 773-779.
46. Kirkwood, S.C., Siemers, E., Bond, C., Conneally, P.M., Christian, J.C. and Foroud, T. (2000) Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch. Neurol., 57, 1040-1044.
47. Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E. and Dom, R. (2004) Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation-a longitudinal follow-up study. J. Neurol., 251, 935-942.
48. Paulsen, J.S. (2009) Functional imaging in Huntington's disease. Exp. Neurol., 216, 272-277.
49. Rosas, H.D., Koroshetz, W.J., Chen, Y.I., Skeuse, C., Vangel, M., Cudkowicz, M.E., Caplan, K., Marek, K., Seidman, L.J., Makris, N., Jenkins, B.G. and Goldstein, J.M. (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology, 60, 1615-1620.
50. Rosas, H.D., Salat, D.H., Lee, S.Y., Zaleta, A.K., Pappu, V., Fischl, B., Greve, D., Hevelone, N. and Hersch, S.M. (2008) Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain, 131, 1057-1068.
51. Wolf, R.C., Vasic, N., Schonfeldt-Lecuona, C., Ecker, D. and Landwehrmeyer, G.B. (2009) Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum. Brain Mapp., 30, 327-339.
52. Brooks, S., Higgs, G., Jones, L. and Dunnett, S.B. (2010) Longitudinal analysis of the behavioural phenotype in Hdh((CAG)150) Huntington's disease knock-in mice. Brain Res. Bull., doi:10.106/j.brainresbull.2010.05.004.
53. Murphy, K.P., Carter, R.J., Lione, L.A., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B. and Morton, A.J. (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J. Neurosci., 20, 5115-5123.
54. Giralt, A., Saavedra, A., Carretón, O., Xifró, X., Alberch, J. and Pérez-Navarro, E. (2011) Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Hum. Mol. Genet., 20, 4262-4247.
55. Won, J. and Silva, A.J. (2008) Molecular and cellular mechanisms of memory allocation in neuronetworks. Neurobiol. Learn. Mem., 89, 285-292.
56. Saura, C.A., Choi, S.Y., Beglopoulos, V., Malkani, S., Zhang, D., Shankaranarayana Rao, B.S., Chattarji, S., Kelleher, R.J III, Kandel, E.R., Duff, K., Kirkwood, A. and Shen, J. (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron, 42, 23-36.
57. Hardingham, G.E., Chawla, S., Cruzalegui, F.H. and Bading, H. (1999) Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels. Neuron, 22, 789-798.
58. Wood, M.A., Attner, M.A., Oliveira, A.M., Brindle, P.K. and Abel, T. (2006) A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn. Mem., 13, 609-617.
59. Oike, Y., Hata, A., Mamiya, T., Kaname, T., Noda, Y., Suzuki, M., Yasue, H., Nabeshima, T., Araki, K. and Yamamura, K. (1999) Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum. Mol. Genet., 8, 387-396.
60. Wood, M.A., Kaplan, M.P., Park, A., Blanchard, E.J., Oliveira, A.M., Lombardi, T.L. and Abel, T. (2005) Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learn. Mem., 12, 111-119.
61. Caccamo, A., Maldonado, M.A., Bokov, A.F., Majumder, S. and Oddo, S. (2010) CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA, 107, 22687-22692.
62. Espana, J., Valero, J., Minano-Molina, A.J., Masgrau, R., Martin, E., Guardia-Laguarta, C., Lleo, A., Gimenez-Llort, L., Rodriguez-Alvarez, J. and Saura, C.A. (2010) beta-Amyloid disrupts activity-dependent gene transcription required for memory through the CREB coactivator CRTC1. J. Neurosci., 30, 9402-9410.
63. Fleischmann, A., Hvalby, O., Jensen, V., Strekalova, T., Zacher, C., Layer, L.E., Kvello, A., Reschke, M., Spanagel, R., Sprengel, R., Wagner, E.F. and Gass, P. (2003) Impaired long-term memory and NR2A-type NMDA receptor-dependent synaptic plasticity in mice lacking c-Fos in the CNS. J. Neurosci., 23, 9116-9122.
64. Guzowski, J.F. (2002) Insights into immediate-early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches. Hippocampus, 12, 86-104.
65. Hallam, T.M. and Bourtchouladze, R. (2006) Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction. Cell Mol. Life Sci., 63, 1725-1735.
66. Lagali, P.S., Corcoran, C.P. and Picketts, D.J. (2010) Hippocampus development and function: role of epigenetic factors and implications for cognitive disease. Clin. Genet., 78, 321-333.
67. Lockett, G.A., Wilkes, F. and Maleszka, R. (2010) Brain plasticity, memory and neurological disorders: an epigenetic perspective. Neuroreport, 21, 909-913.
68. Tsankova, N., Renthal, W., Kumar, A. and Nestler, E.J. (2007) Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci., 8, 355-367.
69. Levenson, J.M., O'Riordan, K.J., Brown, K.D., Trinh, M.A., Molfese, D.L. and Sweatt, J.D. (2004) Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem., 279, 40545-40559.
70. Levenson, J.M. and Sweatt, J.D. (2005) Epigenetic mechanisms in memory formation. Nat. Rev. Neurosci., 6, 108-118.
71. Stefanko, D.P., Barrett, R.M., Ly, A.R., Reolon, G.K. and Wood, M.A. (2009) Modulation of long-term memory for object recognition via HDAC inhibition. Proc. Natl Acad. Sci. USA, 106, 9447-9452.
72. Rouaux, C., Loeffler, J.P. and Boutillier, A.L. (2004) Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders. Biochem. Pharmacol., 68, 1157-1164.
73. Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M. and Tsai, L.H. (2007) Recovery of learning and memory is associated with chromatin remodelling. Nature, 447, 178-182.
74. Fischer, A., Sananbenesi, F., Mungenast, A. and Tsai, L.H. (2010) Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol. Sci., 31, 605-617.
75. Kilgore, M., Miller, C.A., Fass, D.M., Hennig, K.M., Haggarty, S.J., Sweatt, J.D. and Rumbaugh, G. (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology, 35, 870-880.
76. Ricobaraza, A., Cuadrado-Tejedor, M., Perez-Mediavilla, A., Frechilla, D., Del Rio, J. and Garcia-Osta, A. (2009) Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology, 34, 1721-1732.
77. Ricobaraza, A., Cuadrado-Tejedor, M., Marco, S., Perez-Otano, I. and Garcia-Osta, A. (2010) Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus, doi:10.1002/hipo.20883.
78. Bousiges, O., Vasconcelos, A.P., Neidl, R., Cosquer, B., Herbeaux, K., Panteleeva, I., Loeffler, J.P., Cassel, J.C. and Boutillier, A.L. (2010) Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus. Neuropsychopharmacology, 35, 2521-2537.
79. Albasser, M.M., Poirier, G.L. and Aggleton, J.P. (2010) Qualitatively different modes of perirhinal-hippocampal engagement when rats explore novel vs. familiar objects as revealed by c-Fos imaging. Eur. J. Neurosci., 31, 134-147.
80. Guzowski, J.F., Lyford, G.L., Stevenson, G.D., Houston, F.P., McGaugh, J.L., Worley, P.F. and Barnes, C.A. (2000) Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci., 20, 3993-4001.
81. Labrousse, V.F., Costes, L., Aubert, A., Darnaudery, M., Ferreira, G., Amedee, T. and Laye, S. (2009) Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice. PLoS ONE, 4, e6006.
82. Fontan-Lozano, A., Romero-Granados, R., Troncoso, J., Munera, A., Delgado-Garcia, J.M. and Carrion, A.M. (2008) Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice. Mol. Cell Neurosci., 39, 193-201.
83. Ito, H., Yoshimura, N., Kurosawa, M., Ishii, S., Nukina, N. and Okazawa, H. (2009) Knock-down of PQBP1 impairs anxiety-related cognition in mouse. Hum. Mol. Genet., 18, 4239-4254.
84. Dompierre, J.P., Godin, J.D., Charrin, B.C., Cordelieres, F.P., King, S.J., Humbert, S. and Saudou, F. (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntingtońs disease by increasing tubulin acetylation. J. Neurosci., 27, 3571-3583.
85. Ennaceur, A. and Delacour, J. (1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav. Brain Res., 31, 47-59.
86. Gines, S., Bosch, M., Marco, S., Gavalda, N., Diaz-Hernandez, M., Lucas, J.J., Canals, J.M. and Alberch, J. (2006) Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain. Eur. J. Neurosci., 23, 649-658.